SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-002915
Filing Date
2020-03-25
Accepted
2020-03-25 17:51:45
Documents
1
Period of Report
2020-03-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-48442.html 4  
1 PRIMARY DOCUMENT marketforms-48442.xml 4 8397
  Complete submission text file 0001214659-20-002915.txt   9745
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11 SUMMIT LANE GREENVILLE DE 19807
Business Address
Grant Stuart M. (Reporting) CIK: 0001783415 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 20743375